Literature DB >> 19604065

Smokeless tobacco: the epidemiology and politics of harm.

Carl V Phillips1, Karyn K Heavner.   

Abstract

The health burden from tobacco smoking results almost entirely from inhalation of the components of smoke, although this is not widely known. The primary benefit of smoking is nicotine delivery, but nicotine can be obtained without combustion. Thus there is potential for tobacco harm reduction (THR), the substitution of lower-risk nicotine products for smoking. Epidemiological evidence suggests that smokeless tobacco causes about one one-hundredth the health risk of smoking. Despite the practice of harm reduction being widely accepted in public health, however, THR has faced fierce opposition from antitobacco activists. These activists have effectively misled the public about what aspect of smoking cigarettes causes the harm, convincing them that nicotine and tobacco themselves are harmful, ignoring the smoke. In the interests of promoting public health and rescuing science from politics, experts on inhalation hazards and health could play an important role in educating the public and policy makers about THR.

Entities:  

Mesh:

Year:  2009        PMID: 19604065     DOI: 10.1080/13547500902965476

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  9 in total

Review 1.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 2.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

3.  The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use.

Authors:  David T Levy; Zhe Yuan; Yameng Li
Journal:  BMC Public Health       Date:  2018-06-05       Impact factor: 3.295

4.  The impact of product information and trials on demand for smokeless tobacco and cigarettes: evidence from experimental auctions.

Authors:  Matthew C Rousu; Richard J O'Connor; James F Thrasher; Kristie M June; Maansi Bansal-Travers; James Pitcavage
Journal:  Prev Med       Date:  2013-12-07       Impact factor: 4.018

5.  The Minnesota SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use.

Authors:  David T Levy; Zhe Yuan; Yameng Li; Ann W St Claire; Barbara A Schillo
Journal:  Am J Prev Med       Date:  2019-10       Impact factor: 5.043

6.  Estimating demand for alternatives to cigarettes with online purchase tasks.

Authors:  Richard J O'Connor; Kristie M June; Maansi Bansal-Travers; Matthew C Rousu; James F Thrasher; Andrew Hyland; K Michael Cummings
Journal:  Am J Health Behav       Date:  2014-01

7.  Can cigarette alternatives deliver a safer fix?

Authors:  Cynthia Washam
Journal:  Environ Health Perspect       Date:  2011-07       Impact factor: 9.031

8.  The Kentucky SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use.

Authors:  Luz María Sánchez-Romero; Zhe Yuan; Yameng Li; David T Levy
Journal:  Int J Health Policy Manag       Date:  2022-05-01

9.  Prescription medication use of United States military service members by therapeutic classification.

Authors:  Joseph J Knapik; Daniel W Trone; Ryan A Steelman; Emily K Farina; Harris R Lieberman
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.